Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Archive
- 2024/Volume 45
- 2023/Volume 44
- 2022/Volume 43
- 2021/Volume 42
- 2020/Volume 41
- 2019/Volume 40
- 2018/Volume 39
- 2017/Volume 38
- 2016/Volume 37
- 2015/Volume 36
- 2014/Volume 35
- 2013/Volume 34
- 2012/Volume 33
- 2011/Volume 32
- 2011/Volume 31
- 2009/Volume 30
- 2008/Volume 29
- 2007/Volume 28
- 2006/Volume 27
- 2005/Volume 26
Rare Gynecological Malignancies
Deadline for manuscript submissions: 31 December 2021
Print Special Issue Flyer (2)Special Issue Editor
Guest Editor
Aristotelis Bamias, MDE-MailWebsite
2nd Propaedeutic Dept of Internal Medicine, National & Kapodistrian University of Athens, ATTIKON University Hospital, Athens, Greece
Interests: Urogenital and Gynaecological Cancer
Guest Editor
Michalis Liontos, MD, PhDE-MailWebsite
Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Interests: ovarian cancer; gynecological oncology; clinical research; cancer biology; biomarkers
Special Issue Information
Dear Colleagues,
Gynecological cancers are characterized by rare entities more frequently than any other system. For example, all epithelial and non-epithelial neoplasms of the ovary are designated as rare cancers, with the exception of High Grade Serous carcinomas. Analogously, rare carcinomas are encountered among uterine and cervical carcinomas. The management of these neoplasms is affected by their rarity. Clinical trials investigating therapeutic modalities for these cances are seldom and frequently clinical decisions are based on retrospective data, small non-randomized trials or experts‘ opinion. However, data arising from the molecular analysis of these tumours have offered novel insights in their pathogenesis and new therapeutic opportunities. In addition, many european countries organize centres of excellence in order to provide optimal care for the patients with rare gynecological malignancies. Under this perspective, the scope of this special issue is to comprehensively present novel data regarding rare gynecological cancers and to disseminate experts‘ opinions that could assist in the appropriate managemen of these patients.
Prof. Aristotelis Bamias and Dr. Michalis Liontos
Guest Editors
Keywords
Rare cancers;Ovarian cancer;Cervical cancer;Endometrial cancer;Biomarkers
Manuscript Submission Information
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Share This Special Issue
Published Papers (2 papers)
Systemic therapy is effective in the management of leiomyomatosis
Systemic therapy is effective in the management of leiomyomatosis
DOI: 10.22514/ejgo.2022.013
(This article belongs to the Special Issue Rare Gynecological Malignancies)
18 Sertoli-leydig cell tumors of the ovary: analysis of a single institution database
18 Sertoli-leydig cell tumors of the ovary: analysis of a single institution database
DOI: 10.22514/ejgo.2022.018
(This article belongs to the Special Issue Rare Gynecological Malignancies)
Abstracted / indexed in
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.